Drug details

Vueway (gadopiclenol injection)

type of Diagnostic Imaging Agents

Vueway (gadopiclenol) is a gadolinium-based contrast agent indicated in adult and pediatric patients aged 2 years and older for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in the central nervous system (brain, spine, and associated tissues) and the body (head and neck, thorax, abdomen, pelvis, and musculoskeletal system).

This drug may have the following side effects:

• headache,
• dizziness, and
• injection site reactions (pain, warmth, and coldness),
• localized swelling.

The following drugs are related to Vueway, either as a replacement or used together:

• Ablavar (gadofosveset trisodium injection)
• Clariscan (gadoterate meglumine injection)
• Dotarem (gadoterate meglumine for use with magnetic resonance imaging)
• Elucirem (gadopiclenol injection)
• Eovist (gadoxetate disodium injection)
• Gadavist (gadobutrol)
• Vasovist (gadofosveset trisodium injection for intravenous use)
• Magnevist (gadopentetate dimeglumine)
• ProHance Multipack (gadoteridol injection)
• ProHance (gadoteridol injection solution)
• Teslascan (mangafodipir)